{"url":"https://lda.senate.gov/api/v1/filings/638fea63-56d5-408e-93b2-eae60f2e75da/","filing_uuid":"638fea63-56d5-408e-93b2-eae60f2e75da","filing_type":"Q4","filing_type_display":"4th Quarter - Report","filing_year":2023,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/638fea63-56d5-408e-93b2-eae60f2e75da/print/","filing_document_content_type":"text/html","income":"40000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Amy Jensen","dt_posted":"2024-01-22T16:28:15-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"300 New Jersey Avenue, NW","registrant_address_2":"Suite 900","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":401104582,"url":"https://lda.senate.gov/api/v1/registrants/401104582/","house_registrant_id":null,"name":"SPLITOAK STRATEGIES LLC","description":"Health care consulting","address_1":"300 New Jersey Avenue, NW","address_2":"Suite 300","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"SARAH EGGE","contact_telephone":"+1 703-203-7992","dt_updated":"2026-07-30T12:56:37.934245-04:00"},"client":{"id":51733,"url":"https://lda.senate.gov/api/v1/clients/51733/","client_id":51733,"name":"AMRYT PHARMA","general_description":"Rare disease biopharmaceutical company","client_government_entity":null,"client_self_select":false,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-05-10"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Ensuring access to treatments for rare disease; Value of rare disease research and development; FDA process improvements for rare disease; Improving access for patients with orphan diseases; Improved use of FDA rare disease review processes; HR 5539 Orphan Cures Act","foreign_entity_issues":"Ownership and therefore indirect interest","lobbyists":[{"lobbyist":{"id":67072,"prefix":null,"prefix_display":null,"first_name":"AMY","nickname":null,"middle_name":null,"last_name":"JENSEN","suffix":null,"suffix_display":null},"covered_position":"1999-2001 Assistant to the Speaker for Policy; 2003-2005 Special Assistant to the President for Legislative Affairs","new":true},{"lobbyist":{"id":67714,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":"KUEHL","last_name":"EGGE","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant to Senator Bob Kerrey; Senior Budget Analyst for Democratic staff of the Senate Budget Committee (Sen. Kent Conrad); Deputy Staff Director, Joint Select Committee on Deficit Reduction","new":true},{"lobbyist":{"id":143356,"prefix":"mrs","prefix_display":"MRS.","first_name":"KRISTEN","nickname":null,"middle_name":"ELIZABETH","last_name":"SHATYNSKI","suffix":null,"suffix_display":null},"covered_position":"Professional Staff, House E&C Committee to Cathy McMorris Rodgers (2021-22) & Greg Walden (2017-21); Leg. Asst., Rep. Greg Walden, 4/2015-1/2017; Leg. Asst., Rep. Jackie Walorski, 10/2013-4/2015; Leg. Asst., Rep. Devin Nunes, 10/2012-10/2013","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Improve access to home infusion services; HR 5397 the Joe Fiandra Access to Home Infusion Act; HR 6363 Further Continuing Appropriations and other Extensions Act of 2024","foreign_entity_issues":"Ownership and therefore indirect interest","lobbyists":[{"lobbyist":{"id":67714,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":"KUEHL","last_name":"EGGE","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant to Senator Bob Kerrey; Senior Budget Analyst for Democratic staff of the Senate Budget Committee (Sen. Kent Conrad); Deputy Staff Director, Joint Select Committee on Deficit Reduction","new":false},{"lobbyist":{"id":67072,"prefix":null,"prefix_display":null,"first_name":"AMY","nickname":null,"middle_name":null,"last_name":"JENSEN","suffix":null,"suffix_display":null},"covered_position":"1999-2001 Assistant to the Speaker for Policy; 2003-2005 Special Assistant to the President for Legislative Affairs","new":false},{"lobbyist":{"id":143356,"prefix":"mrs","prefix_display":"MRS.","first_name":"KRISTEN","nickname":null,"middle_name":"ELIZABETH","last_name":"SHATYNSKI","suffix":null,"suffix_display":null},"covered_position":"Professional Staff, House E&C Committee to Cathy McMorris Rodgers (2021-22) & Greg Walden (2017-21); Leg. Asst., Rep. Greg Walden, 4/2015-1/2017; Leg. Asst., Rep. Jackie Walorski, 10/2013-4/2015; Leg. Asst., Rep. Devin Nunes, 10/2012-10/2013","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}